Pankowski and Ferraro's workers' compensation suit

Pankowski and Ferraro’s workers’ compensation suit was an early attempt to hold Humboldt Chemical responsible for serious illnesses contracted during long employment at the Xerxes plant. The case turned on a difficult question of proof: whether Xerxine exposure caused the men’s conditions when smoking, drinking, pollution, and the limits of medical knowledge at the time could all be used to dispute that connection. They lost, but later medical records and the prospect of claims by hundreds of workers made the case an unfinished struggle rather than a closed matter.

Background and the Workers’ Claim

Pankowski and Ferraro approached Frederick Manheim in early 1983, both gravely ill and in financial difficulty. Ferraro had worked at the plant since 1959 and Pankowski since 1961. They had left their jobs about two years earlier, when illness made continuing impossible; because they had quit rather than remained employed until their conditions were formally addressed, they could not collect disability benefits. Manheim did not think they had been told that disability was an option. The two had learned that Xerxine might cause health problems and hoped to establish that their conditions were job-related, allowing them to receive workers’ compensation.

The company had begun making Xerxine in the 1950s, when its toxic effects were not widely understood. The solvent was made by adding chlorine to ethylene gas, and its production released chlorinated vapors. Breathing those vapors could harm the liver, kidneys, and central nervous system. As industrial-health research developed during the 1960s and 1970s, investigators identified toxicity at relatively low concentrations. Xerxes responded by installing air scrubbers and better sealing pipes; by the late 1970s, its airborne concentrations had been brought down to the federal standard of 50 parts per million. Those later controls did not settle what years of earlier exposure had done to workers.

Litigation and Defeat

Manheim first approached Humboldt Chemical in an effort to resolve the matter, but the company would not negotiate. With both clients seriously ill and uncertain how much time they had, he filed suit rather than delay. He understood that a successful claim could also benefit their families: if the men died after winning, an indemnity payment could provide substantial support. In Illinois, the payment for families of workers who died on the job was described as a quarter of a million dollars. The stakes were therefore both immediate and practical, even as Manheim knew that a victory experienced only after death would come too late for his clients themselves.

The suit received an early docket, which Manheim attributed to his connections despite working on the South Side. But the company had potent arguments against causation. Both men smoked, Pankowski drank heavily, and both had lived all their lives in South Chicago, where polluted air offered another possible source of illness. Humboldt Chemical argued that the evidence could not distinguish harm from Xerxine from harm caused by those other factors. It also argued that the men had worked at the plant before the chemical’s toxicity was known, and that the company had operated according to the medical knowledge available at the time. The case was decided in the company’s favor. A skilled appellate lawyer found no adequate basis to pursue an appeal, and Manheim could not find a way around the evidentiary obstacles.

The suit’s defeat did not establish that Xerxine had played no role in the men’s illnesses. It reflected how difficult it was to prove a particular cause when workplace exposure overlapped with other risks and the most serious exposure had occurred before the danger was officially recognized. The legal defenses that succeeded in court thus left a gap between the workers’ lived history at the plant and what they could demonstrate under the case’s conditions.

Medical Records and the Case’s Second Life

Later, a specialist’s review of records from the Xerxes plant gave the underlying concern a much broader evidentiary basis. The records covered about 500 employees between 1955 and 1982. Changes in blood values—including creatine, blood urea nitrogen, bilirubin, hematocrit, hemoglobin, and white blood count—were consistent with the development of kidney, liver, and bone-marrow dysfunction. Ferraro’s records extended from 1957 to 1982, and his death from aplastic anemia in 1983 was part of the medical history considered in the review.

The same review summarized Louisa Djiak’s records from 1963 to 1982. It indicated noticeable renal damage by 1967 and severe damage by 1969; her diffuse symptoms, including itching, fatigue, and headaches, began around 1979. The specialist found that the blood changes in the records were consistent with Xerxine exposure. These findings did not undo the judgment in the men’s suit, but they altered the context in which its failure could be understood: the case had been argued as a dispute over two workers, while the records suggested a long-running pattern across the workforce.

Threats, Resources, and the Prospect of Further Claims

During the period when an appeal was being considered, Manheim received a threatening phone call. The caller did not name the case, referring only in general terms to the dangers of using the appellate system. Manheim said he became angry and pressed for an appeal afterward, but the legal advice and the available grounds did not change. He did not report the call to the state’s attorney. The episode raised the possibility that intimidation could shadow formal legal procedures, while leaving the caller’s identity and connection to the suit unstated.

When V. I. Warshawski later asked whether Manheim would organize and manage action for hundreds of former Xerxes employees, and possibly current ones, the proposal meant a transformation of his small practice. It would require researchers, associates, and paralegals, while larger firms might try to take over once they saw the possibility of contingency fees. Manheim recalled the earlier threat, but said he could not live with himself if a chance to win the case were now available and he passed it up merely to preserve a quiet practice. His acceptance turned the lost suit into a point of departure: the original claims had failed, but the later evidence and the scale of possible harm reopened the question of what justice for the workers might require.